Herein, enzymatic inhibitions involving α-amylase and α-glucosidase were investigated for DM type II, acetyl- (AChE) and butyryl-cholinesterase (BChE) for Alzheimer’s disease, and tyrosinase for skin disorders. This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.